Vaccine Contract Manufacturing Market Size Analysis, Drivers, Restraints, Key Factors Forecast, 2022–2032

The global vaccine contract manufacturing market size was USD 3.6 Billion in 2022 and is expected to reach USD 9.36 Billion in 2032, and register a revenue CAGR of 11.2% during the forecast period.


The global Vaccine Contract Manufacturing Market had a valuation of USD 3.6 billion in 2022, and it is anticipated to surge to USD 9.36 billion by 2032, displaying a robust compound annual growth rate (CAGR) of 11.2% over the forecast period. Key drivers behind this remarkable revenue expansion include the increasing prevalence of infectious diseases, a growing demand for innovative vaccines, and heightened government funding for vaccine research and development.

In an effort to boost production capacity, expedite time-to-market, and ensure cost-efficiency, vaccine manufacturers are increasingly entrusting their manufacturing operations to Contract Manufacturing Organizations (CMOs). The accelerated growth in revenue within the vaccine contract manufacturing market is a direct outcome of this strategic outsourcing trend.

Get a sample of the report @

Competitive Landscape:

  • Emergent BioSolutions Inc.
  • Lonza Group AG
  • Samsung Biologics Co., Ltd.
  • Catalent, Inc.
  • Fujifilm Diosynth Biotechnologies
  • Wuxi Biologics
  • AGC Biologics
  • Thermo Fisher Scientific Inc.
  • Rentschler Biopharma SE
  • Cytiva (Danaher Corporation)

To know more about the report @

Driving Factors:

  1. Increasing Prevalence of Infectious Diseases: The rising incidence of infectious illnesses, such as pandemics and seasonal outbreaks, drives the demand for vaccines, thereby boosting the vaccine contract manufacturing market.
  2. Demand for Novel Vaccines: Growing awareness and demand for innovative and more effective vaccines for both existing and emerging diseases encourage vaccine manufacturers to expand their production capabilities.
  3. Government Funding: Governments around the world are increasing their investment in vaccine research and development, offering grants and incentives to vaccine manufacturers, which stimulates the market.
  4. Outsourcing Trends: Vaccine makers are increasingly outsourcing their manufacturing operations to specialized Contract Manufacturing Organizations (CMOs) to improve efficiency, reduce costs, and speed up production.


  1. Regulatory Challenges: The vaccine manufacturing industry is highly regulated, and navigating complex regulatory requirements can be a significant barrier to entry and expansion in the market.
  2. Quality Control Concerns: Ensuring the quality, safety, and efficacy of vaccines is paramount, and any lapses in quality control can lead to setbacks in production and market challenges.
  3. Capacity Constraints: Meeting the increasing global demand for vaccines, especially during public health crises, can be challenging due to capacity constraints, which may limit market growth.
  4. Cost-Intensive Processes: Vaccine manufacturing involves expensive and resource-intensive processes, which can put pressure on profit margins and hinder market growth.

Request a customization of the report @

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web:

Direct Line: +1-212-710-1370a


Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @

Browse More Latest Reports @